ST. ALBANS —The COVID-19 vaccine produced by Pfizer-BioNTech was approved yesterday by the U.S. Food and Drug Administration’s vaccine advisory panel. The vaccine will likely now be authorized for emergency use, allowing Vermont to receive it as early as Tuesday, Dec. 15.
Of Vermont’s initial allocation of 5,850 doses, Northwestern Medical Center has been allotted a limited number in the first phase. Pharmacy Manager Jessica Aboelezz anticipates NMC’s allotment will last three weeks.
Here’s who will be vaccinated by NMC first:
“Other NMC staff and providers will have the opportunity to be vaccinated through NMC in future phases that are under development,” Aboelezz said in a statement to the Messenger.
Aboelezz also said staff and providers included in the first vaccination phase should be ready, but flexible, given that dates and numbers are still not concrete.
“After months of addressing the pandemic, it is exciting to be at this point,” Aboelezz said.
Dr. John Minadeo, NMC’s chief medical officer, said the hospital at this time has sufficient freezer space to accept and store the vaccine. Pfizer’s must be stored at minus 70 degrees Celsius.
Comments
No comments on this item Please log in to comment by clicking here